Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector

Nature Biotechnology

Volumn 15, Issue 12, 1997, Pages 1285-1289

  Draghia Akli, Ruxandra ^a   Li, Xuyang ^a   Schwartz, Robert J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DNA vaccine; Gene therapy; Growth hormone; Skeletal alpha actin

Indexed keywords

GROWTH HORMONE RELEASING FACTOR;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GROWTH HORMONE RELEASE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA, RECOMBINANT; GENETIC VECTORS; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; RECOMBINANT PROTEINS; RNA, MESSENGER; SWINE;

ANIMALIA; SUS SCROFA; TRIXIS;

EID: 0030659758     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1197-1285     Document Type: Article

References (45)

1. Scanlon, M.F., Issa, B.G., and Dieguez, C. 1996. Regulation of growth hormone secretion. Horm. Res. 46:149-154.
2. Enright, W.J., Prendiville, D.J., Splcer, L.J., Strieker, P.R., Moloney, A.P., Mowles, T.F., and Campbell, R.M. 1993. Effects of growth hormone-releasing factor and(or) thyrotropin-releasing hormone on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifers. J. Anim. Sci. 71:2395-2405.
3. Enright, W.J., Chapin, L.T., Moseley, W.M., Zinn, S.A., and Tucker, H.A. 1986, Growth hormone-releasing factor stimulates milk production and sustains growth hormone release in Holstein cows. J. Dairy Sci. 69:344-351.
4. LeRoith, D., Yanowski, J., Kaldjian, E.P., Jaffe, E.S., LeRoith, T., Purdue, K., et al. 1996. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137:1071-1079.
5. Kotzmann, H., Koller, M., Czernin, S., Clodi, M., Svoboda, T, Riedl, M., et al. 1994. Effect of elevated growth hormone concentrations on the phenotype and functions of human lymphocytes and natural killer cells. Neuroendocrinology 60:618-625.
6. Iranmanesh, A., Lizarralde, G., and Veldhuis, J.D. 1991. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73:1081-1088.
7. D’Costa, A.R, Ingram, R.L., Lenham, J.E., and Sonntag, W.E. 1993. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J. Reprod. Fertil. Suppi. 48:87-98.
8. Corpas, E., Harman, S.M., and Blackman, M.R. 1993. Human growth hormone and human aging. Endocr. Rev. 14:20-39.
9. Marcus, R., Butterfield, G., Holloway, L, Gilliland, L, Baylink, D.J., Hintz, R.L, and Sherman, B.M. 1990. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70:519-527.
10. Salomon, R, Cuneo, R.C., Hesp, R., and Sonksen, P.H. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321:1797-803.
11. Corpas, E., Harman, S.M., Pineyro, M.A., Roberson, R., and Blackman, M.R. 1993. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-l levels in old men. J. Clin. Endocrinol. Metab. 76:134-138.
12. Mayo, K.E., Cerelli, G.M., Lebo, R.V., Bruce, B.D., Rosenfeld, M.G., and Evans, R.M. 1985. Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. Proc. Natl. Acad. Sci. USA 82:63-67.
13. Mayo, K.E., Vale, W., Rivier, J., Rosenfeld, M.G., and Evans, R.M. 1983. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature 306:86-88.
14. Riddell, D.C., Mallonee, R., Phillips, J.A., Parks, J.S., Sexton, LA., and Hamerton, J.L 1985. Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Som. Cell Mol. Genet. 11:189-195.
15. Esch, F.S., Bohlen, P., Ling, N.C., Brazeau, P.E., Wehrenberg, W.B., Thorner, M.O., et al. 1982. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem. Biophys. Res. Comm. 109:152-158.
16. Thorner, M.O., Frohman, L.A., Leong, D.A., Thominet, J., Downs, T., Hellmann, P., et al. 1984.Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J. Clin. Endocrinol. Metab. 59:846-849.
17. Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., and Jani, A. 1992. Long-term persistence of plasmld DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
18. Wolff, J.A., Maione, R.W., Williams, R, Chong, W., Acsadi, G., Jani, A., and Feigner, P.L. 1990. Direct gene transfer Into mouse muscle in vivo. Science 247:1465-1468.
19. Davis, H.L, Whalen, R.G., and Demeneix, B.A. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:151-159.
20. Wells, D.J. 1993. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 332:179-182.
21. Bergsma, D.J., Grichnik, J.M., Gossett, L.M., and Schwartz, R.J. 1986. Delimitation and characterization of cis-acting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal alpha-actin gene. Mol. Cell. Biol. 6:2462-2475.
22. Chow, K.L. and Schwartz, R.J. 1990. A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene. Mol. Cell. Biol. 10:528-538.
23. Lee, T.C., Zhang, Y. and Schwartz, R.J. 1994. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myo-genesls. Oncogene 9:1047-1052.
24. Ling, N., Baird, A., Wehrenberg, W.B., Ueno, N., Munegumi, T, and Brazeau, R 1984. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochem. Biophys. Res. Comm. 123:854-861.
25. Bertherat, J., Bluet-Pajot, M.T., and Epelbaum, J. 1995. Neuroendocrine regulation of growth hormone. Eur. J. Endocrinol. 132:12-24.
26. Low, L.C. 1993.The therapeutic use of growth-hormone-releasing hormone. J. Pediatr. Endocrinol. 6:15-20.
27. Yao, S.N., Smith, K.J., and Kurachi, K. 1994. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Therapy 1:99-107.
28. Tripathy, S.K., Svensson, E.C., Black, H.B., Goldwasser, E., Margalith, M. Hobart, P.M., and Leiden, J.M. 1996. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA 93:10876-10880.
29. Tripathy, S.K., Black, H.B., Goldwasser, E., and Leiden, J.M. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Medicine 2:545-550.
30. Levy, M.Y., Barron, L.G., Meyer, K.B., and Szoka, F.C. Jr. 1996. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Therapy 3:201-211.
31. Cao, Y, Wagner, J.K., Hindmarsh, P.C., Eble, A., and Mullis, R.E. 1995. Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor. Pediatr. Res. 38:962-966.
32. Cogan, J.D., Phillips, J.A. III, Sakati, N., Frisch, H., Schober, E., and Milner, R.D. 1993. Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J. Clin. Endocrinol. Metab. 76:1224-1228.
33. Vnencak-Jones, C.L., Phillips, J.A. III, Chen, E.Y., and Seeburg, P.H. 1988. Molecular basis of human growth hormone gene deletions. Proc. Natl. Acad. Sci. USA 85:5615-5619.
34. Amselem, S., Duquesnoy, P., Duriez, B., Dastot, F., Sobrier, M.L., Valleix, S., and Goossens, M. 1993.Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum. Mol. Genet. 2:355-359.
35. Amselem, S., Duquesnoy, P., Sobrier, M.L., and Goossens, M. 1991. Molecular defects in the growth hormone receptor. A Paediatr. Scandinavica Suppl. 377:81-86.
36. Meacham, L.R., Brown, M.R., Murphy, T.L., Keret, R., Silbergeld, A., Laron, Z., and Parks, J.S. 1993. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron’s syndrome. J. Clin. Endocrinol. Metab. 77:1379-1383.
37. Parks, J.S., Abdul-Latif, H., Kinoshita, E., Meacham, L.R., Pfaffle, R.W., and Brown, M.R. 1993. Genetics of growth hormone gene expression. Hormone Res. 40:54-61.
38. Parks, J.S., Pfaffle, R.W., Brown, M.R., Abdul-Latif, H., and Meacham, L.R. 1995. Growth hormone deficiency, pp. 473-90 in Molecular endocrinology: basic concepts and clinical correlations. Weintraub, B.D. (ed.) Raven Press, New York.
39. Wang, Y, DeMayo, F.J., Tsai, S.Y, and O’Malley, B.W. 1997. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology 15:239-243.
40. Chow, K.L., Hogan, M.E., and Schwartz, R.J. 1991. Phased cis-acting promoter elements interact at short distances to direct avian skeletal alpha-actin gene transcription. Proc. Natl. Acad. Sci. USA 88:1301-1305.
41. French, B.A., Bergsma, D.J., and Schwartz, R.J. 1990. Analysis of a CR1 (chicken repeat) sequence flanking the 5’ end of the gene encoding alpha-skeletal actin. Gene 88:173-80.
42. Doumit, M.E. and Merkel, R.A. 1992. Conditions for isolation and culture of porcine myogenic satellite cells. Tissue & Cell 24:253-262.
43. Tanner, J.W., Davis, S.K., McArthur, N.H., French, J.T., and Welsh, T.H., Jr. 1990. Modulation of growth hormone (GH) secretion and GH mRNA levels by GH-releasing factor, somatostatin and secretagogues in cultured bovine adenohy-pophysial cells. J. Endocrinol. 125:109-115.
44. Barb, C.R., Estienne, M.J., Kraeling, R.R., Marple, D.N., Rampacek, G.B., Rahe, C.H., and Sartin, J.L. 1991. Endocrine changes in sows exposed to elevated ambient temperature during lactation. Domest. Anim. Endocrinol. 8:117-127.
45. Danko, I., Fritz, J.D., Jiao, S., Hogan, K., Latendresse, J.S., and Wolff, J.A. 1994. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Therapy 1:114-121.